Paul Goddard, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 6,000 shares at $131.92 ($793K) on 2013-07-01, disclosed to the SEC on 2013-07-02.
Scheduled sale ($793k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.92 | 3,500 | $462K | 58.2% |
| 2 | $132.63 | 2,500 | $332K | 41.8% |
| Total | $132.22 avg | 6,000 | $793K | 100% |
| Filing → |
| ONXX | SELL | 2013-04-11 | $190K | — | Filing → |
| ONXX | SELL | 2013-03-11 | $85K | — | Filing → |
| ONXX | SELL | 2013-03-05 | $297K | — | Filing → |